Janet Lambert – VJRegenMed

Progress in the face of COVID-19

admin_vjr_user — Fri, 09 Oct 2020 16:47:09 +0000

Coronavirus has impacted almost all industries. Despite this, the regenerative medicine (RegenMed) sector has shown to be incredibly resilient. Janet Lambert, CEO, Alliance for Regenerative Medicine (ARM), Washington, DC, talks on COVID-19, and some of the issues that have arisen for RegenMed as well as positive adaptations that may remain. This interview took place during the 2020 Meeting on the Mesa congress.

Meeting on the Mesa 2020 goes virtual

admin_vjr_user — Fri, 09 Oct 2020 16:47:09 +0000

The Cell & Gene Meeting on the Mesa is a key annual conference for the regenerative sector, bringing together key players in both industry and academia to further advances and cutting-edge research. Janet Lambert, CEO, Alliance for Regenerative Medicine (ARM), San Francisco, CA, discusses the meeting and the move to a virtual platform in light of the COVID-19 pandemic. This interview took place during the 2020 Meeting on the Mesa congress.

Key themes and discussions at Meeting on the Mesa 2020

admin_vjr_user — Fri, 09 Oct 2020 16:47:09 +0000

Janet Lambert, MBA, Alliance for Regenerative Medicine (ARM), Washington, DC, outlines the key themes and discussions that will be presented at the 2020 Meeting on the Mesa. Such insights include the realities of bringing gene therapies to market, the technologies that will disrupt cell therapy, cell and gene therapies for chronic conditions, and a special session on the challenges related to commercialization. This interview took place during the 2020 Meeting on the Mesa congress.

Introducing ARM: The Alliance for Regenerative Medicine

admin_vjr_user — Fri, 09 Oct 2020 16:47:09 +0000

The Alliance for Regenerative Medicine (ARM) is the only organization focussed solely on the issues facing regenerative medicine. In this video, Janet Lambert, CEO, the Alliance for Regenerative Medicine (ARM), Washington, DC, talks on the goals of ARM, with the key aim being to deliver safe and effective cell & gene therapies and tissue-engineered products to patients. This interview took place during the 2020 Meeting on the Mesa congress.

Challenges facing the regenmed sector in 2020

admin_vjr_user — Fri, 09 Oct 2020 16:47:09 +0000

Janet Lambert, CEO, Alliance for Regenerative Medicine (ARM), Washington, DC, touches on the various barriers that currently challenge the rich and exciting regenerative medicine field. Such challenges include manufacturing, regulatory issues, and the reimbursement models currently in place. This interview took place during the 2020 Meeting on the Mesa congress.